SciSight Ecosystem
WoS ESCI Q1Hybrid

Core Evidence

Country: United States•WoS SCIE Quartile: Q1•Identifier (ISSN):1555-1741(Print)/1555-175X(Online)•Articles / Year: 4
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (Hirsch Index)
N/A

papers with at least that number of citations each

WoS: ESCIQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
4articles/year
83.33% Gold OA•0% Original Research

Aims & Scope

Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch. The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups The emerging evidence on new drugs is reviewed at key stages of development and evaluated against unmet needs

Topics Covered (Recognized by AI)
MedicineBiology95.4%Internal medicine94.7%Genetics63.2%Pathology61.8%Pharmacology52%Chemistry46.1%Biochemistry42.8%Endocrinology42.1%Surgery40.8%Immunology36.8%Psychology32.2%Adverse effect32.2%Psychiatry28.9%Oncology28.9%Intensive care medicine27%Alternative medicine24.3%Bioinformatics23.7%Receptor21.7%Clinical trial21.7%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Core Medical Pub
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

13 year
YearImpact FactorArticles / YearTotal Citations
20230——
2020—550
2019—6234
2018—374
2017—276
2016—5217
2015—8212
2014—14567
2013—7302
2012—12384
2011—6184
2010—9163
2009—22462
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Core Evidence

WoS Q1
000020230.00
Annual Impact Factor Metric
2023:0

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 31d42896-a2a7-4265-880a-5ba59ec53dc3
Database Updated: 2026-09-29